General Product Description
Canephron Urinary Tract Support is for the symptomatic relief of medically diagnosed localised[1] urinary tract infections (UTIs), comparable with antibiotic treatment[2] - without the negative consequences.[3]
Canephron’s anti-inflammatory[4], analgesic[5], anti-spasmodic[6] and bacterial flushing[7] effects, deal with all the major symptoms of localised UTIs in a comparable manner to that of an antibiotic.[8]
Key Features
Directions for Use
Adults and children aged over 12: Take 1 coated tablet, 3 times daily. Do not exceed the recommended dose. Can be used in conjunction with antibiotics.
Warnings
Always read and follow the directions for use
Only recommend for use in adults and children 12 years and over. If pain or irritation persists for more than 48 hours, consult your doctor. If you notice blood in your urine, please seek immediate medical attention. Keep out of reach of children.
Contains sugars: glucose, sucrose and lactose.
Ingredients
Each coated tablets contains 36 mg Centaurium erythraea (centaury) herb powder, 36 mg Levisticum officinale (lovage) root powder, 36 mg Rosmarinus officinalis L. (rosemary) leaf powder.
[1] Localised (and Systemic) UTIs is the revised classification approach to UTIs developed by the EAU in their recent guideline update (2025) and adopted by USANZ. It serves to enhance consistency in clinical practice and replaces “uncomplicated” and “complicated”
[2] Wagenlehner F. M. et al., Urol Int., 2018, 101(3), 327-336.
[3] Anthony WE, Wang B, Sukhum KV, et al. Acute and persistent effects of commonly used antibiotics on the gut microbiome and resistome in healthy adults. Cell Rep. 2022;39(2):110649.
[4] Nausch B. et al., Phytomedicine 2019 (60) 152987, Butler et al., Urol Int 2023;107:778–784
[5] Nausch B. et al., Phytomedicine 2019 (60) 152987, Alidjanov J. et al., Investig Clin Urol 2020;61:498-507
[6] BrenneisC. et al., Poster 13th International Congress Ethnopharmacology, Graz 2012, Sabadash, Shulyak, Clinical Phytoscience2017 3:9
[7] KünstleG. et al., Poster EAU, Mailand2013
[8] Wagenlehner F. M. et al., Urol Int., 2018, 101(3), 327-336
